Amanote Research
Register
Sign In
Which Aminoglycoside or Fluoroquinolone Is More Active Against Mycobacterium Tuberculosis in Mice?
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.41.3.607
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
March 1, 1997
Authors
N Lounis
B Ji
C Truffot-Pernot
J Grosset
Publisher
American Society for Microbiology
Related search
Rifabutin Is Active Against Mycobacterium Abscessus in Mice
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active Against Mycobacterium Tuberculosis in Vivo
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Indoleamides Are Active Against Drug-Resistant Mycobacterium Tuberculosis
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Transport Function: Which Choroid Plexus Is More Active?
International Journal of Advanced Research
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium Tuberculosis
Science
Multidisciplinary
Philosophy of Science
History
Protective and Therapeutic Efficacy of Mycobacterium Smegmatis Expressing HBHA-hIL12 Fusion Protein Against Mycobacterium Tuberculosis in Mice
PLoS ONE
Multidisciplinary
Prevalence and Molecular Characterization of Fluoroquinolone-Resistant Mycobacterium Tuberculosis Isolates in China
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Using Mycobacterium Tuberculosis Single Nucleotide Polymorphisms to Predict Fluoroquinolone Treatment Response
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Active Surveillance or Radical Prostatectomy? Which Treatment Is Best?
Bratislava Medical Journal